Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Early Detection of Cancer | 6 | 2023 | 3089 | 0.820 |
Why?
|
Lung Neoplasms | 8 | 2023 | 13112 | 0.700 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2013 | 67 | 0.460 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1585 | 0.450 |
Why?
|
Estrogen Receptor beta | 1 | 2013 | 175 | 0.430 |
Why?
|
Intestinal Neoplasms | 1 | 2014 | 319 | 0.390 |
Why?
|
beta Catenin | 2 | 2014 | 1060 | 0.390 |
Why?
|
Oligonucleotides | 1 | 2014 | 572 | 0.380 |
Why?
|
Preoperative Care | 4 | 2020 | 2251 | 0.370 |
Why?
|
Mass Screening | 4 | 2023 | 5251 | 0.350 |
Why?
|
Estrogen Receptor alpha | 1 | 2013 | 577 | 0.340 |
Why?
|
Lymph Nodes | 1 | 2019 | 3476 | 0.300 |
Why?
|
Health Services Accessibility | 2 | 2023 | 5136 | 0.290 |
Why?
|
Unnecessary Procedures | 2 | 2020 | 432 | 0.280 |
Why?
|
Thoracic Surgical Procedures | 2 | 2020 | 342 | 0.270 |
Why?
|
Transforming Growth Factor beta | 1 | 2013 | 2006 | 0.260 |
Why?
|
Colon | 1 | 2013 | 1772 | 0.260 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 6773 | 0.250 |
Why?
|
Vermont | 2 | 2023 | 85 | 0.250 |
Why?
|
Physicians, Women | 2 | 2021 | 486 | 0.240 |
Why?
|
New Hampshire | 2 | 2023 | 172 | 0.240 |
Why?
|
Radiography, Thoracic | 2 | 2021 | 1265 | 0.240 |
Why?
|
Rural Population | 4 | 2023 | 2207 | 0.230 |
Why?
|
Lymph Node Excision | 2 | 2019 | 1262 | 0.220 |
Why?
|
Faculty, Medical | 2 | 2021 | 1181 | 0.210 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6363 | 0.200 |
Why?
|
Medical Waste Disposal | 1 | 2021 | 12 | 0.200 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2020 | 29 | 0.180 |
Why?
|
Fibromatosis, Aggressive | 2 | 2011 | 118 | 0.180 |
Why?
|
Esophagectomy | 2 | 2023 | 447 | 0.180 |
Why?
|
Thoracic Diseases | 1 | 2020 | 97 | 0.170 |
Why?
|
Smoking Cessation | 2 | 2020 | 2071 | 0.150 |
Why?
|
General Surgery | 2 | 2021 | 1636 | 0.150 |
Why?
|
Thymidylate Synthase | 1 | 2016 | 75 | 0.140 |
Why?
|
Research Support as Topic | 1 | 2020 | 705 | 0.130 |
Why?
|
Minority Groups | 1 | 2023 | 1222 | 0.130 |
Why?
|
Aberrant Crypt Foci | 1 | 2013 | 12 | 0.120 |
Why?
|
Blood Transfusion | 1 | 2020 | 1301 | 0.120 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2015 | 230 | 0.120 |
Why?
|
Paneth Cells | 1 | 2013 | 99 | 0.110 |
Why?
|
Postoperative Care | 1 | 2020 | 1485 | 0.110 |
Why?
|
Smad4 Protein | 1 | 2013 | 163 | 0.110 |
Why?
|
Pneumonectomy | 1 | 2019 | 1098 | 0.110 |
Why?
|
Maximum Tolerated Dose | 1 | 2014 | 892 | 0.100 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2924 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2018 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1642 | 0.090 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1862 | 0.090 |
Why?
|
Prognosis | 3 | 2019 | 29052 | 0.090 |
Why?
|
Lung Diseases | 1 | 2020 | 1887 | 0.090 |
Why?
|
Internship and Residency | 2 | 2022 | 5787 | 0.080 |
Why?
|
Radiography | 1 | 2020 | 7010 | 0.080 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11036 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2013 | 784 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20121 | 0.080 |
Why?
|
Humans | 22 | 2023 | 743811 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2023 | 77410 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2010 | 780 | 0.070 |
Why?
|
Female | 15 | 2023 | 380020 | 0.070 |
Why?
|
Aged | 8 | 2021 | 163178 | 0.070 |
Why?
|
Middle Aged | 10 | 2021 | 213241 | 0.070 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 21824 | 0.070 |
Why?
|
Quality Improvement | 1 | 2020 | 3750 | 0.060 |
Why?
|
Postoperative Period | 2 | 2020 | 1841 | 0.060 |
Why?
|
Male | 13 | 2023 | 349776 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3677 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2542 | 0.060 |
Why?
|
Intestines | 1 | 2014 | 1923 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12954 | 0.060 |
Why?
|
Systems Analysis | 1 | 2023 | 171 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3038 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2023 | 15281 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2453 | 0.050 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 1632 | 0.050 |
Why?
|
Wound Healing | 1 | 2011 | 2776 | 0.050 |
Why?
|
Stem Cells | 1 | 2013 | 3566 | 0.050 |
Why?
|
United States | 6 | 2023 | 69859 | 0.040 |
Why?
|
Chest Tubes | 1 | 2020 | 150 | 0.040 |
Why?
|
Career Mobility | 1 | 2021 | 262 | 0.040 |
Why?
|
Risk-Taking | 1 | 2023 | 986 | 0.040 |
Why?
|
Thorax | 1 | 2020 | 547 | 0.040 |
Why?
|
Patients | 1 | 2023 | 899 | 0.040 |
Why?
|
Mice | 2 | 2014 | 81154 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2023 | 20827 | 0.030 |
Why?
|
Adult | 5 | 2021 | 213889 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18027 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 520 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21675 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1404 | 0.030 |
Why?
|
Schools, Medical | 1 | 2020 | 879 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8385 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2016 | 684 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1582 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3550 | 0.030 |
Why?
|
Counseling | 1 | 2020 | 1523 | 0.030 |
Why?
|
Fluorouracil | 1 | 2016 | 1619 | 0.030 |
Why?
|
Leadership | 1 | 2021 | 1357 | 0.030 |
Why?
|
Animals | 2 | 2014 | 168660 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 23398 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2291 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2021 | 1877 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3117 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2515 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3391 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3317 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2010 | 551 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11360 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 29777 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8637 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7270 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 63042 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8430 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2942 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25032 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8436 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39001 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40038 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53250 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 72252 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16674 | 0.010 |
Why?
|
Concepts
(121)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_